2019
DOI: 10.4103/eus.eus_65_19
|View full text |Cite
|
Sign up to set email alerts
|

Rapid on-site evaluation (ROSE) with EUS-FNA: The ROSE Slooks beautiful

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 40 publications
0
15
0
Order By: Relevance
“…Mahmoudi et al (2008) completed a crosssectional study on 199 cytological brush samples and showed 77 patients (41%) with positive results for malignancy (25). Result-related variables included age, (13). In our study, ROSE was performed in 25% of cases and augmented the sensitivity of cytology to 80%.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Mahmoudi et al (2008) completed a crosssectional study on 199 cytological brush samples and showed 77 patients (41%) with positive results for malignancy (25). Result-related variables included age, (13). In our study, ROSE was performed in 25% of cases and augmented the sensitivity of cytology to 80%.…”
Section: Discussionmentioning
confidence: 69%
“…The risk of the complications of malignancy is lower than the percutaneous method (12). In 20% of cases, this technique may lead to uncertain and suspicious results due to technical or tissue issues (13). Diagnostic accuracy has increased using a new generation of needles and ultrasound devices along with immunological and molecular diagnostic methods (14).…”
Section: Introductionmentioning
confidence: 99%
“…Rapid on-site evaluation (ROSE), which is intended to provide the real-time evaluation of sample adequacy and diagnostic yield, remains one of the most controversial topics in the field of EUS-FNA [ 27 ]. Currently, EUS-FNA with ROSE is mainly applied in pancreatic lesions.…”
Section: Discussionmentioning
confidence: 99%
“…In 12 cases with malignant esophageal strictures, ROSE depicted cancer cells in 11 cases, which demonstrated the potential application of ROSE as a supplementary method. While EUS-FNA, combined with ROSE, demonstrated non-inferior performance compared to EUS-FNA without ROSE, the major obstacles to the wide application of ROSE include limiting pathologist staffing, and a longer procedures time [ 27 ]. It should be addressed that in patient 11, even though both cytological and histological studies reported suspicious round tumor cells, with little cytoplasm, while no malignant cell was reported by ROSE, the final diagnosis was an esophageal glomus tumor, which is an extremely rare esophageal neoplasm [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
“… 15–17 Some reports have shown that ROSE can improve diagnostic accuracy rates and reduce the number of needle passes during EUS-FNA. 18–20 However, ROSE is time-consuming, costly, and unapplicable in many hospitals due to a lack of pathologists. Currently, puncture needle selection remains the main focus of many researchers.…”
Section: Discussionmentioning
confidence: 99%